Diabetes-related social and economic costs amounted to DKK31.8
billion (USD4.75 billion) in 2011, corresponding to...
About the Life Sciences Blog
Industry insights from the IHS Markit Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.
IHS Markit Blog Home »